New temporary members of the CCE Operational Board

Laura Pelz and Tanja Jutzi have been strengthening the CCE team for the NCT Heidelberg during the parental leave of Monika Huber and Petra Oberrauch.
Katie Mills is managing the University of Cambridge contributions to CCE whilst Rebecca Bradley is on maternity leave. 

Laura started on June 1st at the NCT Heidelberg and will take over for national cooperations. She also works in the CCE Education & Training task force and the summer school team. Laura is biologist and did her doctoral thesis in Berlin at the Max-Delbrück Center for Molecular Medicine. Thereafter she worked at the Federal Office of Consumer Protection and Food Safety in the national reference laboratory for genetically modified organisms. She is happy to use now all her previous experience to push networking of cancer researchers and institutes forward.

 Tanja also started in June. She will support the Heidelberg contributions to CCE, coordinate the Imaging task force led by Heinz Schlemmer and work in the summer school team. She gained experience in the scientific landscape during her post-doctoral cancer research in Heidelberg and Vancouver. Tanja also worked for several years as project manager for large German biomedical research networks (NGFN, e:Med systems medicine). She likes to contribute to a good team spirit and to implement tasks cooperatively in a solution-oriented manner. ​

 Katie Mills joined the CCE Operational Board in May 2021. Katie’s focus is to provide support in the coordination of the Genomics taskforce led by Valterri Wirta, and the Cambridge led DART programme work packages led by Richard Baird and Thomas Jaki.  Katie joins us with 10 years post-doctorate experience in cancer prevention and early diagnosis from the University of Cambridge.

Are you interested in collaborating with us, or do you wish to get more involved in our activities?

Contact us, and we will get back to you:

If you are working for a CCE-centre, please contact your local CCE coordinator.

If you are a patient and interested in treatments or you want to join a trial, please contact your local hospital.